NYSE:SGFY
Signify Health
- Stock
Last Close
30.47
28/03 20:00
Market Cap
8.93B
Beta: 0.36
Volume Today
9.63M
Avg: 2.65M
PE Ratio
−41.22
PFCF: 128.17
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 2.55M - | 2.10M 17.65% | 3.15M 50% | 7.15M 126.98% | ||
average receivables | 123.65M - | 252.40M 104.12% | 299.95M 18.84% | 242.25M 19.24% | ||
book value per share | 1.73 - | 5.83 237.18% | 5.39 7.53% | 6.66 23.54% | 3.56 46.56% | |
capex per share | -0.08 - | -0.16 94.66% | -0.21 32.45% | -0.17 17.53% | -0.16 5.33% | |
capex to depreciation | -0.30 - | -0.39 26.82% | -0.55 41.67% | -0.40 26.09% | -0.48 18.37% | |
capex to operating cash flow | -0.37 - | -0.61 66.18% | -0.78 28.19% | -0.22 71.91% | -0.29 31.16% | |
capex to revenue | -0.04 - | -0.05 31.08% | -0.06 9.90% | -0.04 33.78% | -0.04 4.99% | |
cash per share | 0.12 - | 0.17 35.78% | 0.44 159.60% | 4.02 818.91% | 2.64 34.28% | |
days of inventory on hand | ||||||
days payables outstanding | 5.17 - | 0.83 83.88% | 5.19 523.53% | 7.21 38.81% | ||
days sales outstanding | 44.18 - | 150.13 239.82% | 178.38 18.81% | 142.29 20.23% | 82.92 41.72% | |
debt to assets | 0.53 - | 0.31 40.86% | 0.41 32.17% | 0.30 27.75% | 0.53 77.57% | |
debt to equity | 1.12 - | 0.45 59.41% | 0.70 54.78% | 0.56 19.65% | 1.47 160.67% | |
dividend yield | 0.00 - | 0.00 22.95% | 0.00 63.90% | |||
earnings yield | -0.01 - | -0.01 1.38% | -0.00 49.61% | 0.00 248.99% | -0.03 725.24% | |
enterprise value | 5.41B - | 5.42B 0.20% | 5.56B 2.56% | 2.06B 63.00% | 4.95B 140.42% | |
enterprise value over ebitda | 151.63 - | 61.91 59.17% | 64.01 3.38% | 15.52 75.75% | -178.65 1,250.91% | |
ev to operating cash flow | 152.05 - | 130.06 14.46% | 127.87 1.69% | 15.85 87.61% | 50.50 218.68% | |
ev to sales | 16.02 - | 10.81 32.53% | 9.11 15.72% | 2.66 70.79% | 6.14 130.84% | |
free cash flow per share | 0.14 - | 0.10 28.00% | 0.06 42.53% | 0.60 959.60% | 0.40 34.17% | |
free cash flow yield | 0.00 - | 0.00 28.00% | 0.00 42.53% | 0.04 2,251.68% | 0.01 67.34% | |
graham net net | -1.62 - | -1.54 5.37% | -2.00 30.30% | 1.60 180.08% | -1.82 213.30% | |
graham number | 2.62 - | 4.77 82.35% | 3.26 31.74% | 2.97 8.93% | 7.70 159.49% | |
income quality | -1.23 - | -1.46 18.78% | -3 105.04% | 13.12 537.37% | -0.75 105.73% | |
intangibles to total assets | 0.88 - | 0.80 9.46% | 0.72 8.84% | 0.49 31.76% | 0.45 8.65% | |
interest coverage | -0.34 - | 1.02 398.68% | 1.11 8.76% | 2.85 157.42% | 5.29 85.49% | |
interest debt per share | 1.65 - | 1.76 6.53% | 2.55 45.35% | 2.14 16.40% | 2.17 1.68% | |
inventory turnover | ||||||
invested capital | 0.88 - | 0.28 68.21% | 0.45 60.75% | 0.30 32.89% | 0.58 91.58% | |
market cap | 5.18B - | 5.18B 0% | 5.23B 0.96% | 2.40B 54.17% | 5.05B 110.67% | |
net current asset value | -253.10M - | -171.30M 32.32% | -239.10M 39.58% | 366.30M 253.20% | -127M 134.67% | |
net debt to ebitda | 6.42 - | 2.74 57.36% | 3.78 38.23% | -2.56 167.81% | 3.75 246.38% | |
net income per share | -0.18 - | -0.17 1.38% | -0.09 49.61% | 0.06 167.13% | -0.74 1,360.15% | |
operating cash flow per share | 0.22 - | 0.25 17.13% | 0.26 3.32% | 0.77 193.62% | 0.56 27.82% | |
payables turnover | 70.63 - | 438.14 520.35% | 70.27 83.96% | 50.62 27.96% | ||
receivables turnover | 8.26 - | 2.43 70.57% | 2.05 15.83% | 2.57 25.36% | 4.40 71.59% | |
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.39 - | -0.10 74.68% | -0.03 65.36% | 0.01 126.60% | -0.14 1,581.01% | |
revenue per share | 2.06 - | 3.05 48.51% | 3.68 20.53% | 4.59 24.54% | 4.57 0.36% | |
roe | -0.10 - | -0.03 70.75% | -0.02 45.50% | 0.01 154.34% | -0.21 2,458.27% | |
roic | -0.01 - | 0.02 223.68% | 0.02 17.23% | 0.06 198.30% | 0.13 127.91% | |
sales general and administrative to revenue | 0.64 - | 0.49 23.40% | 0.50 1.96% | |||
shareholders equity per share | 1.73 - | 5.83 237.18% | 5.39 7.53% | 6.66 23.54% | 3.56 46.56% | |
stock based compensation to revenue | 0.01 - | 0.01 16.55% | 0.02 120.98% | 0.02 13.87% | 0.05 219.32% | |
tangible asset value | -244.50M - | -149.70M 38.77% | -209.60M 40.01% | 440.50M 310.16% | 32.40M 92.64% | |
tangible book value per share | -1.49 - | -0.91 38.77% | -1.26 38.68% | 2.61 306.64% | 0.18 92.96% | |
working capital | 33.90M - | 140.90M 315.63% | 199.60M 41.66% | 817.50M 309.57% | 306.10M 62.56% |
All numbers in USD (except ratios and percentages)